News Agency
Men's Weekly

The Results of Phase II Clinical Study of KN046 Plus Chemotherapy as First-line Treatment for Metastatic NSCLC were Published in Cell Reports Medicine

  • Written by PR Newswire

SUZHOU, China, March 22, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the phase II clinical research results of anti- PD-L1/CTLA-4 bispecific antibody KN046 plus chemotherapy as first-line treatment for metastatic non-small cell lung cancer (NSCLC) were published online in the renowned journal Cell Reports Medicine (I...

Read more: The Results of Phase II Clinical Study of KN046 Plus Chemotherapy as First-line Treatment for...

How Headless CMS Enables Continuous Innovation Without Rebuilding Systems

Innovation is essential for staying competitive in today’s digital landscape, but many businesses struggle to innovate because their systems are not designed for change. Traditional content management systems often require significant redevelopment when new features, channels, or experiences are introduced... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion